Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

For keen veggie growers and rose enthusiasts, aphids can be a real bane to your gardening dreams. These little insects are ...

Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited ...

CSHL postdoc Iacopo Gentile has devised a new system for identifying redundant genes and predicting how certain genetic ...

As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P.

Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

In October, Poethig and fellow researcher Aaron Leichty — a former graduate student in Poethig’s lab — published research on ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...